[CHINA BIOLOGIC PRODUCTS, INC. UNDERWRITING AGREEMENT June 27, 2014 June 27, 2014 Morgan Stanley & Co. International plc for the Underwriters named in Schedule II hereto Ladies and Gentlemen: Company Underwriters Manager Selling Stockholder Firm Shares Company Additional Shares Selling Stockholder Additional Shares Additional Shares Shares. Common Stock Sellers China Biologic Products, Inc., a Delaware corporation (the “ Commission Shelf] [China Biologic Announces Pricing of Public Offering of Common Stock BEIJING, China – June 27, 2014 The Company intends to use the proceeds from the offering primarily for general corporate purposes. In addition, if appropriate opportunities arise in the future to acquire or invest in complementary businesses, products or technologies, the Company may use a portion of the net proceeds] []

[]

[China Biologic Announces Favorable Reduction in Value Added Tax Rate BEIJING, China – June 23, 2014 About China Biologic China Biologic is a leading plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and] []